Mulakan
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

Tiada dagangan
Lihat pada Carta Super
Gambaran keseluruhan Kewangan Idea Perbincangan Teknikal Bermusim
Bon

Bon ABBVD

Di bawah adalah senarai bon-bon korporat AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1. Pelabur selalunya memilih bon syarikat kerana kestabilan meningkat mereka semasa ketidakstabilan pasaran. Kaji harga, hasil dan statistik lain dan cari pelaburan yang boleh dipercayai.
Simbol
YTM %
Volum
Harga %
Kupon %
Tarikh Matang
Jumlah tertunggak
Nilai muka
Jumlah denominasi min
Pengeluar
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
—8.11 M97.33%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
—1.38 M92.59%4.85%2044-06-151.01 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
—2.54 M100.87%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
—22.85 M99.78%5.60%2055-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
—1.25 M101.67%4.65%2028-03-151.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
—0111.17%2.95%2026-11-219.24 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
—16 K77.52%4.85%2044-06-1565.23 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
—26 K76.04%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
—10.68 M91.24%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
—12.2 M102.62%5.20%2035-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
—9.53 M97.75%4.55%2035-03-151.68 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
—5.25 M103.10%4.88%2030-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
—0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
—12 K77.91%4.63%2042-10-0167.49 M USD1,000.00 USD2,000.00 USDActavis, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
—3.96 M102.41%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
—0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
—1.4 M91.26%4.63%2042-10-01389.22 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
—26 K90.47%3.20%2029-11-2162.52 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
—5.94 M88.59%4.40%2042-11-062.6 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
—19.86 M96.42%3.20%2029-11-215.44 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
—0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
—16 K89.58%4.55%2035-03-15107.65 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
—20.8 M82.26%4.25%2049-11-215.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
—16.2 M101.10%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
—480 K98.50%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
—5.68 M98.67%2.95%2026-11-213.99 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
—1.97 M90.99%4.75%2045-03-15827.09 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
—5 M103.39%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
—11.89 M102.10%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
—13.35 M97.05%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
—9.3 M88.53%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
—0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
—097.15%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
—098.16%2.13%2029-06-01506.09 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
—094.75%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
—099.29%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9AbbVie Inc. 4.45% 14-MAY-2046
—086.47%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
—098.70%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
—090.58%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
—090.36%2.63%2028-11-1572.11 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029
—094.03%2.13%2029-06-0136.46 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
—0100.32%2.63%2028-11-15427.79 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABBAbbVie Inc. 4.7% 14-MAY-2045
—089.87%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABEAbbVie Inc. 0.75% 18-NOV-2027
—096.72%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.